The latest trading day saw Pfizer (PFE) settling at $25.60, representing a -0.43% change from its previous close.

AbbVie Inc. enters the obesity market with GUBamy, a promising amylin analog. Click here to find out why ABBV stock is a Buy.

As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results ...

Sponsored by the Indian Council of Social Science Research (ICSSR), the seminar served as a platform for experts, researchers, and students to discuss the role of artificial intelligence (AI) in ...

Núñez Feijóo, the leader of the Spanish People's Party (Partido Popular/EPP), the main opposition force in Parliament, met with Sánchez (PSOE/S&D) for talks on how the government intends to reach its ...

A 400-home neighbourhood at Hazelhurst Farm in Worsley, a site allocated in Greater Manchester’s Places for Everyone development plan, will go to committee for a decision next week.

This article has been corrected to reflect that the senators asked UpScriptHealth to respond. In August 2024, Pfizer Inc ...

The Hopkins School Board heard from the district's special education department at its latest work session, learning its ...

Taylen Green returns to quarterback the Razorbacks in 2025, but few targets that he threw to in 2024 will be back.

PACCAR utilizes its comprehensive Supplier Performance Management Program (SPM) to evaluate supplier achievements in the areas of product development, operations, aftermarket support, and alignment ...

American Water (NYSE: AWK), the largest regulated water and wastewater utility company in the U.S., highlights how customers can easily manage their account and locate information at any time of the ...

Pfizer closed at $25.60, slipping 0.43% in the latest session, outperforming broader market losses. While the S&P 500 dropped ...